Fujiki K, Kuwabara Y, Nakajima A, Nishigaki I, Ikeuchi T
Ophthalmic Paediatr Genet. 1987 Mar;8(1):19-21. doi: 10.3109/13816818709028510.
Esterase D was qualitatively and quantitatively analyzed in the red blood cells from 50 retinoblastoma patients who had been followed-up at Juntendo University and their family. In only one case with deletion of chromosome No. 13 (q12.3-q21.2), was the esterase D activity (type 2) 1.47 Unit/gHb which was approximately 50% of the level in normals. Additional retinoblastoma patients and their family members, 77 parents and 25 siblings, showed a normal range of esterase D level in their own phenotypes. These facts confirmed that the deletion of an esterase D locus was infrequent (approximately 2% in our series) in retinoblastoma patients. It was also compatible with the published data that the range of deletion of chromosome was No. 13 (q12.3-q21.2) involving 13q14.
对50名在顺天堂大学接受随访的视网膜母细胞瘤患者及其家属的红细胞进行了酯酶D的定性和定量分析。仅在1例13号染色体(q12.3 - q21.2)缺失的病例中,酯酶D活性(2型)为1.47单位/gHb,约为正常水平的50%。另外的视网膜母细胞瘤患者及其家庭成员,77名父母和25名兄弟姐妹,其自身表型中的酯酶D水平在正常范围内。这些事实证实,视网膜母细胞瘤患者中酯酶D基因座的缺失并不常见(在我们的系列研究中约为2%)。这也与已发表的数据相符,即染色体缺失范围为13号染色体(q12.3 - q21.2),涉及13q14。